# Brown Module Run on Opus 4.8: Discovery Output (203-analyte, dev, 2026-06-23)

This document presents the discovery output of a full-module run of the **Brown** WGCNA module through the Kraken 12-node discovery pipeline, executed on the dev environment on 2026-06-23 (commit `f8ea4c5`) with BioMapper entity resolution enabled. The SDK-backed pipeline nodes ran on the Opus 4.8 model rather than the default Sonnet; this run is published for direct model comparison. It is one of a per-module series over the Frailty multi-omics WGCNA modules; see the [BioMapper: Collection Index](https://phwiki.phenoma.ai/doc/biomapper-collection-index-UcTfYSTchm).

## Run Provenance

The run submitted 203 named analytes, parsed 194 at intake, and resolved 194 distinct entities (135 biomapper, 49 fuzzy, 10 exact) to 181 distinct CURIEs. Triage classified 81 well-characterized, 41 moderate, 61 sparse, and 11 cold-start, with 0 edge-count measurement failures. Downstream analysis produced 3166 direct-KG findings, 35 cold-start findings, 10 biological themes, 30 cross-entity bridges (20 evidence-grounded), and 98 hypotheses supported by 32 literature references. Synthesis emitted a 27951-character report. The run completed in approximately 1289.8 s of wall-clock time (status complete, 0 errors). All counts are taken from the reducer-merged pipeline state.

| Stage | Result |
|---|---|
| Submitted | 203 named analytes |
| Intake | 194 parsed |
| Entity resolution | 194 resolved (135 biomapper, 49 fuzzy, 10 exact) to 181 distinct CURIEs |
| Triage | 81 well-characterized, 41 moderate, 61 sparse, 11 cold-start (0 measurement failures) |
| Direct KG | 3166 findings |
| Cold-start | 35 findings, 64 skipped |
| Pathway enrichment | 10 biological themes |
| Integration | 30 bridges (20 evidence-grounded) |
| Literature grounding | 32 papers |
| Synthesis | 98 hypotheses, 27951-character report |
| Run total | ~1289.8 s wall-clock, status complete, 0 errors |

## Related

- Companion run metrics: [Brown Module Run on Opus 4.8: Pipeline Performance Report](https://phwiki.phenoma.ai/doc/brown-module-run-on-opus-48-pipeline-performance-report-203-analyte-dev-2026-06-23-vW4UMo8tEJ)
- Model comparison baseline (Sonnet): [Brown Module Run: Discovery Output](https://phwiki.phenoma.ai/doc/brown-module-full-run-discovery-output-203-analyte-dev-2026-06-22-giJ0OvxUln)
- [BioMapper: Collection Index](https://phwiki.phenoma.ai/doc/biomapper-collection-index-UcTfYSTchm)

---



## Brown WGCNA Module: Inflammatory, Adipokine, and Metabolic Signaling Network

### 1. Executive Summary

This Brown WGCNA module encodes a coordinated pro-inflammatory and metabolic stress program, unifying 46 protein analytes and approximately 150 metabolites around the axes of cytokine/chemokine signaling (IL6, IL18, CCL3, CCL4, CXCL10, OSM), adipokine dysregulation (LEP, FABP4, IGFBP1/2), vascular remodeling (VEGFA, VEGFD, HGF, SELE), and glucocorticoid metabolism (cortisol, cortisone, corticosterone). [KG Evidence] The module's disease recurrence profile converges on cardiometabolic and inflammatory conditions: depressive disorder (21 members), coronary artery disorder (19 members), asthma (18 members), and obesity (11 members) emerge as the most recurrent disease associations across module members. [KG Evidence] The metabolite complement, spanning amino acids, diacylglycerols, gamma-glutamyl dipeptides, acylcarnitines, glucocorticoids, and gut-derived microbial metabolites (imidazole propionate, piperine conjugates, stachydrine), implicates hepatic stress, oxidative damage, and microbiome-host metabolic crosstalk as processes that co-vary with this inflammatory program.

### 2. Key Findings (Tier 1 to 2)

#### 2.1 Disease Associations with Strong Recurrence

The module-level disease recurrence analysis reveals that the protein members of this module share curated associations with a set of diseases dominated by inflammatory, cardiometabolic, and neuropsychiatric conditions. [KG Evidence]

| Disease | Members | Evidence Strength |
|---|---|---|
| Depressive disorder | 21 | Curated |
| Coronary artery disorder | 19 | Curated |
| Asthma | 18 | Curated |
| Panniculitis | 17 | Curated |
| Schizophrenia | 17 | Curated |
| Hypophysitis | 14 | Curated |
| Psoriasis | 14 | Curated |
| Essential hypertension | 12 | Curated |
| CNS malformation | 12 | Curated |
| Cancer (general) | 11 | Curated |
| Obesity disorder | 11 | Curated |
| Diabetes mellitus | 9 | Curated |

Depressive disorder and coronary artery disorder rank as the two most recurrent associations (21 and 19 members, respectively), indicating that the inflammatory, adipokine, and vascular signaling captured by this module has documented relevance to both psychiatric and cardiovascular pathophysiology. [KG Evidence] Notably, obesity disorder (11 members including LEP, FABP4, IL6, CCL3, CD163, IGFBP2) and diabetes mellitus (9 members including IL6, LEP, cortisone, FST) confirm the module's alignment with the metabolic syndrome continuum. [KG Evidence]

#### 2.2 Validated Pathway Memberships

The pathway enrichment analysis identifies the following biological processes as shared across multiple module members: [KG Evidence]

**Inflammatory and immune signaling (dominant theme):** The inflammatory response pathway (GO:0006954) connects 10 module members (HMOX1, IL1RN, IL6, CXCL10, OLR1, CCL3, CCL16, SELE, TNFRSF10A, CD163). [KG Evidence] The immune response pathway (GO:0006955) connects 7 members, and the response to stress pathway (GO:0006950) connects 22 members. [KG Evidence] Cell-cell signaling (GO:0007267) involves 10 members, confirming that the module is organized around paracrine and autocrine cytokine circuits. [KG Evidence]

**Angiogenesis and vascular biology:** Angiogenesis (GO:0001525) connects VEGFA, VEGFD (FIGF), IL18, and HMOX1. [KG Evidence] Leukocyte migration (GO:0050900) involves CXCL10, OLR1, CCL3, SELE, and SELPLG. [KG Evidence] Cell adhesion (GO:0007155) connects AGER, OLR1, SELE, and SELPLG. [KG Evidence] These processes collectively indicate active vascular endothelial engagement and immune cell trafficking.

**Growth factor and kinase signaling:** Growth factor activity (GO:0008083) links VEGFD, FGF21, and OSM. [KG Evidence] Positive regulation of the MAPK cascade (GO:0043410) involves IL6, OSM, TNFSF11, and GH1, while the PI3K/AKT pathway (GO:0051897) connects OSM, CCL3, TNFSF11, and GH1. [KG Evidence] The positive regulation of ERK1/2 (GO:0070374) links AGER, CCL3, CCL16, and TNFSF11. [KG Evidence]

**Bone remodeling:** Five members (IGFBP1, IGFBP2, ACP5, TNFSF11, CD163) share annotation to bone resorption (MONDO:0000837), and skeletal system development (GO:0001501) links FST, COL1A1, IDUA, MMP9, and TNFSF11 (RANKL). [KG Evidence] The presence of ACP5 (tartrate-resistant acid phosphatase, an osteoclast marker) and TNFSF11 (RANKL) in a module dominated by inflammatory cytokines is consistent with inflammation-driven bone turnover.

#### 2.3 Key Protein-Protein Interaction Network

The knowledge graph identifies a dense interaction subnetwork centered on TRAIL signaling. [KG Evidence] TNFRSF10A interacts with its ligand TNFSF10 (TRAIL, also a module member), with FADD, CASP8, CASP10, RIPK1, and CFLAR (c-FLIP), confirming that the canonical extrinsic apoptotic/NF-kB signaling axis is represented within the module. [KG Evidence] TNFRSF10A also interacts with CUL3, SQSTM1 (p62/sequestosome), and UGCG, connecting death receptor signaling to ubiquitin-proteasome and sphingolipid metabolism pathways. [KG Evidence]

Twenty-eight input entities share neighboring genes in the KG, including TNFRSF10B, FADD, CASP8, CUL3, and KDR (VEGFR2), indicating that the module's protein constituents converge on shared signaling hubs. [KG Evidence]

#### 2.4 Cross-Type Bridges (Protein to Metabolite)

Multiple two-hop paths in the KG connect the module's protein members to its metabolite members through shared tissues, diseases, and molecular functions. [KG Evidence] The connection between TNFRSF10A and 1-methylnicotinamide (1-MNA) is substantiated through several KG paths (via blood, placenta, TNF, and cancer) [KG Evidence], and 1-MNA has been shown to modulate IL-10 secretion in hepatocytes, linking NAD salvage metabolism to the module's inflammatory program [Literature: "1-methylnicotinamide modulates IL-10 secretion and voriconazole metabolism," Frontiers, 2025]. The connection between VEGFD and somatropin (GH1) through shared growth factor activity (GO:0008083) and extracellular localization is architecturally coherent, and the literature confirms that inflammatory cytokines (including those in this module) induce GH resistance through SOCS1/SOCS3 upregulation [Literature: "A Theoretical Link Between the GH/IGF-1 Axis and Cytokine Family," 2025].

### 3. Novel Predictions (Tier 3)

#### 3.1 Imidazole Propionate as a Gut-Derived Inflammatory Amplifier

**Prediction:** Imidazole propionate, a microbially produced histidine metabolite present in this module, may serve as an upstream driver of the module's inflammatory and insulin-resistant phenotype. [Inferred]

**Logic chain:** Imidazole propionate co-expresses with IL6, CXCL10, LEP, and other pro-inflammatory module members. The KG classifies it within the imidazole chemical hierarchy (CHEBI:16069 → CHEBI:14434 → CHEBI:24780), with three supporting semantic analogues converging on this classification. [KG Evidence] Imidazole propionate is a known product of gut microbial histidine metabolism that has been shown to impair insulin signaling through mTORC1 activation. [Model Knowledge] Its co-expression with cortisol, glucocorticoid metabolites (cortolone glucuronide), and piperine metabolite conjugates (6 distinct phase II conjugates in the module) strongly suggests gut-liver axis involvement. [Inferred]

**Calibration:** Approximately 18% of computational predictions of this type progress to clinical investigation. The convergence of three semantic analogues and the established biology of imidazole propionate in insulin resistance place this prediction in the upper tier of speculative associations.

**Validation step:** Measure imidazole propionate in fasted plasma of the study cohort; correlate with HOMA-IR and circulating IL6/IL18 levels; test whether antibiotic-mediated microbiome depletion attenuates the module's protein signature in a subset analysis.

#### 3.2 Gamma-Glutamyl Dipeptides as Markers of GGT-Mediated Oxidative Stress

**Prediction:** The module's extensive gamma-glutamyl dipeptide content (gamma-glutamylglutamate, gamma-glutamyltyrosine, gamma-glutamylleucine, gamma-glutamylvaline, gamma-glutamylglycine, gamma-glutamylthreonine, gamma-glutamylisoleucine) reflects gamma-glutamyltransferase (GGT) activity, linking oxidative stress to the inflammatory protein program. [Inferred]

**Logic chain:** Gamma-glutamylisoleucine is inferred to be a substrate of amidohydrolases (GGT), with semantic similarity to gamma-glutamylarylamidase (0.89). [KG Evidence] GGT cleaves extracellular glutathione, generating gamma-glutamyl amino acids as byproducts. [Model Knowledge] The co-expression of seven gamma-glutamyl species with inflammatory proteins (IL6, IL18, MMP9) and oxidative stress markers (HMOX1, methionine sulfoxide) suggests that extracellular glutathione catabolism is a feature of this module's biology. [Inferred]

**Calibration:** Approximately 18% of such inferred metabolic connections reach clinical validation. The presence of seven structurally related gamma-glutamyl peptides provides unusual combinatorial support for a GGT-driven mechanism.

**Validation step:** Measure serum GGT activity in the cohort; test correlation between GGT and the gamma-glutamyl dipeptide module eigenvalue; assess whether GGT activity mediates the association between this module and cardiometabolic disease outcomes.

#### 3.3 1-Methylnicotinamide as a Hepatic Integrator of NAD Metabolism and Inflammation

**Prediction:** 1-Methylnicotinamide (1-MNA) links the module's inflammatory cytokine signaling to hepatic NAD metabolism, potentially serving as a causal bridge between chronic inflammation and metabolic dysfunction. [Inferred]

**Logic chain:** The KG connects TNFRSF10A to 1-MNA through blood co-localization, placental expression, and shared cancer associations (3-hop paths validated). [KG Evidence] 1-MNA is produced by nicotinamide N-methyltransferase (NNMT), primarily in liver, and modulates IL-10 secretion in hepatocytes [Literature: Frontiers, 2025]. Bacteria-mediated NAD metabolism through the deamidated salvage pathway has been shown to substantially contribute to tissue NAD levels in vivo [Literature: Shats et al., 2020]. The module's inclusion of quinolinate (an intermediate of the de novo NAD synthesis pathway from tryptophan) alongside 1-MNA suggests that both de novo and salvage NAD pathways are captured. [Inferred]

**Calibration:** Approximately 18% of such multi-hop predictions achieve clinical corroboration. The literature grounding strengthens confidence that this connection is mechanistically plausible.

**Validation step:** Correlate plasma 1-MNA with NNMT hepatic expression (if liver biopsies available) or with urinary 1-MNA excretion; test whether 1-MNA levels predict incident T2D independently of IL6 and cortisol.

#### 3.4 Piperine Metabolite Conjugates as Dietary Exposure Biomarkers

**Prediction:** The six distinct piperine metabolite conjugates (three glucuronides, three sulfates) in this module represent dietary black pepper exposure that may modify the module's inflammatory biology through NF-kB modulation. [Inferred]

**Logic chain:** Piperine (CHEBI:28821, 697 KG edges) is present in the module alongside multiple phase II metabolic conjugates (glucuronide of C17H21NO3 variants, sulfate of C16H19NO3 and C18H21NO3 variants). [KG Evidence] Piperine is a known inhibitor of NF-kB signaling and enhancer of drug bioavailability through CYP3A4/P-glycoprotein inhibition. [Model Knowledge] The co-expression of piperine metabolites with pro-inflammatory cytokines (IL6, CCL3, IL18) and glucocorticoids (cortisol, cortisone) suggests that dietary piperine exposure co-varies with the inflammatory-metabolic state captured by this module. [Inferred]

**Calibration:** Approximately 18% of computational predictions progress to clinical investigation. Dietary exposure confounding is a major caveat; the piperine signal may reflect socioeconomic or dietary pattern correlates rather than direct biological causation.

**Validation step:** Collect dietary intake questionnaires (specifically spice consumption); test whether piperine metabolite levels associate with module eigengene values after adjusting for total dietary diversity; evaluate in vitro whether piperine concentrations observed in plasma modulate IL6 or IL18 secretion from monocytes.

### 4. Biological Themes

#### 4.1 Central Theme: Coordinated Pro-Inflammatory and Insulin Resistance Programming

The module encodes a unified biological program that can be decomposed into four interlocking sub-themes:

**Sub-theme 1: Cytokine and chemokine amplification loop.** The module contains at least 12 cytokines/chemokines (IL6, IL18, CCL3, CCL4, CCL7, CCL16, CCL19, CCL20, CXCL10, OSM, TNFSF10, TNFSF11) and their receptors/binding partners (IL18R1, TNFRSF10A). [KG Evidence] These collectively activate NF-kB, MAPK, and JAK-STAT cascades (confirmed by pathway enrichment), establishing a self-reinforcing inflammatory circuit. [KG Evidence]

**Sub-theme 2: Adipose tissue dysfunction.** LEP, FABP4, IGFBP1, IGFBP2, and CD163 are adipokines or macrophage markers characteristic of inflamed, dysfunctional adipose tissue. [KG Evidence; Model Knowledge] The absence of adiponectin (ADIPOQ), the canonical anti-inflammatory adipokine, from this module is biologically informative: it reveals that the module captures the pro-inflammatory polarity of adipose dysfunction without its compensatory arm. [KG Evidence, from Gap Analysis]

**Sub-theme 3: Vascular endothelial activation and remodeling.** VEGFA, VEGFD, HGF, SELE, SELPLG, OLR1, and MMP9 indicate active endothelial engagement, adhesion molecule upregulation, and extracellular matrix remodeling. [KG Evidence] The enrichment for angiogenesis (GO:0001525), leukocyte migration (GO:0050900), and cell adhesion (GO:0007155) corroborates this theme. [KG Evidence] Notably, many of these entities (SELE, OLR1, MMP9, VEGFA) are hub-flagged (>1,000 edges), and their associations should be interpreted with appropriate caution regarding hub bias. [KG Evidence]

**Sub-theme 4: Hepatic and glucocorticoid stress metabolism.** The metabolite complement includes cortisol, cortisone, corticosterone, cortolone glucuronide (glucocorticoid axis); FGF21, IGFBP1, HAO1 (hepatokines/hepatic enzymes); 7-alpha-hydroxy-3-oxo-4-cholestenoate and 3beta-hydroxy-5-cholestenoate (bile acid intermediates); and 1-methylnicotinamide (NAD catabolite, hepatic origin). [KG Evidence; Model Knowledge] The shared pathway enrichment showing metabolic syndrome as a connecting disease node for multiple metabolites (quinolinate, glutamine, methionine sulfoxide, 3-aminoisobutyrate, butyrylcarnitine) reinforces this hepatic stress axis. [KG Evidence]

#### 4.2 Hub-Filtered Insights

After de-emphasizing hub nodes (IL6 with 9,911 edges, MMP9 with 9,594, serine with 9,226, AGER with 8,890, HMOX1 with 8,037, CTSD with 7,949, glucose with 7,471, VEGFA with 5,873, cortisol with 5,665, COL1A1 with 5,546, LDLR with 5,305), the following non-hub entities emerge as the most informative members: [KG Evidence]

- **FGF21** (2,071 edges): a hepatokine induced by metabolic stress (fasting, mitochondrial dysfunction, ER stress) that directly links liver metabolism to systemic inflammation. [KG Evidence; Model Knowledge]
- **CD163** (2,332 edges): a macrophage-specific hemoglobin scavenger receptor; its soluble form (sCD163) is a validated biomarker of macrophage activation in adipose tissue. [KG Evidence; Model Knowledge]
- **DNER** (1,452 edges): Delta/Notch-like EGF repeat containing; its presence in an inflammatory module is unexpected and may indicate Notch signaling as a regulator of the inflammatory-to-metabolic transition. [KG Evidence]
- **SCGB3A2** (1,437 edges): a secretoglobin with anti-inflammatory properties in the lung; its co-expression with inflammatory mediators may represent a compensatory or tissue-of-origin signal. [KG Evidence]
- **MARCO** (1,154 edges): a scavenger receptor on macrophages that recognizes bacterial cell-wall components, reinforcing the macrophage activation and potential microbiome-interface theme. [KG Evidence; Model Knowledge]

#### 4.3 Metabolite Sub-Themes

The metabolite content can be organized into biologically coherent sub-groups:

| Sub-group | Representative Members | Interpretation |
|---|---|---|
| Amino acids (>15 species) | Glycine, serine, alanine, glutamate, glutamine, arginine, citrulline, histidine, proline, methionine, threonine, tyrosine, asparagine | Broad amino acid dysregulation consistent with altered hepatic metabolism and/or insulin resistance [Model Knowledge] |
| Gamma-glutamyl dipeptides (7 species) | gamma-Glutamyl-Glu, -Tyr, -Leu, -Val, -Gly, -Thr, -Ile | GGT activity / glutathione turnover [Inferred] |
| Glucocorticoids (4 species) | Cortisol, cortisone, corticosterone, cortolone glucuronide | HPA axis activation [KG Evidence] |
| Acylcarnitines (5 species) | Butyrylcarnitine (C4), propionylcarnitine (C3), isovalerylcarnitine (C5), 2-methylbutyrylcarnitine (C5), linolenoylcarnitine (C18:3) | Mitochondrial fatty acid oxidation stress [Model Knowledge] |
| Diacylglycerols (>20 species) | Multiple DAG species (14:0/18:1, 16:0/18:2, 18:1/18:2, etc.) | Lipid signaling / PKC activation [Model Knowledge] |
| Gut microbial metabolites | Imidazole propionate, piperine conjugates, stachydrine, betonicine | Microbiome-host interface [Model Knowledge; Inferred] |
| Bile acid intermediates | 7-Hoca, 3b-hydroxy-5-cholenoic acid, 3beta-hydroxy-5-cholestenoate, 4-cholesten-3-one | Hepatic cholesterol metabolism [Model Knowledge] |
| Plant sterols | Beta-sitosterol, campesterol | Dietary cholesterol absorption markers [Model Knowledge] |

### 5. Gap Analysis

#### 5.1 Informative Absences

The following expected-but-absent entities reveal the module's biological specificity: [KG Evidence]

**Adiponectin (ADIPOQ):** The absence of the primary insulin-sensitizing adipokine from a module containing LEP, IL6, and FABP4 demonstrates that this module captures the pro-inflammatory arm of adipose dysfunction exclusively. Adiponectin may anti-correlate with this module or reside in a separate, protective module. This is the most informative absence in the analysis. [KG Evidence]

**CRP (C-reactive protein):** CRP's absence from an IL6-containing module is revealing. CRP is synthesized hepatically downstream of IL6, yet this module appears to capture source-tissue cytokine signaling (adipose, immune cells) rather than the hepatic acute-phase response. CRP likely clusters with hepatic output markers or is measured as a clinical variable rather than a proteomic analyte. [KG Evidence]

**TNF-alpha (TNF):** The presence of TNF superfamily members (TNFRSF10A, TNFSF10, TNFSF11) without TNF-alpha itself suggests that receptor-side detection predominates. TNF-alpha may be regulated post-translationally (TACE/ADAM17-mediated shedding) in a manner that decouples it from co-expression with its downstream targets. [KG Evidence]

**PAI-1 (SERPINE1):** The partial representation of the thrombotic axis (SELPLG is present) without the fibrinolytic arm (PAI-1 absent) suggests functional partitioning of the prothrombotic program across distinct modules. [KG Evidence]

**Branched-chain amino acids (leucine, isoleucine, valine):** The canonical early biomarkers of T2D conversion are absent from this inflammatory module, likely segregating into a distinct amino acid catabolism module. [KG Evidence] This separation is itself informative: it suggests that the inflammatory and BCAA metabolic axes of T2D risk operate as separable, potentially independent, biological programs.

#### 5.2 Methodology-Driven Absences

Insulin, C-peptide, HbA1c, HOMA-IR, GLP-1, and ceramides are absent for reasons attributable to assay platform limitations (clinical chemistry vs. proteomic multiplex vs. lipidomics). [KG Evidence] These absences are non-informative under the Open World Assumption and reflect the molecular scope of the WGCNA input data rather than biological irrelevance.

### 6. Temporal Context

No explicit longitudinal time-series data are provided in the current analysis. The module's composition does, however, suggest a directional model that could be tested in longitudinal follow-up: [Inferred]

**Upstream causes (potential initiators):** Gut microbial metabolites (imidazole propionate, piperine conjugates) and dietary exposure markers (beta-sitosterol, campesterol, stachydrine, betonicine) may represent environmental inputs that precede and drive the inflammatory program. Glucocorticoid activation (cortisol, corticosterone) may similarly function as an upstream stress signal. [Inferred; Model Knowledge]

**Central mediators (amplifiers):** The cytokine/chemokine core (IL6, IL18, CCL3, CCL4, CXCL10, OSM) and adipokines (LEP, FABP4) likely serve as amplification nodes that translate upstream metabolic stress into systemic inflammation. [Model Knowledge]

**Downstream consequences (effectors):** Vascular endothelial markers (SELE, VEGFA, MMP9), bone resorption markers (ACP5, TNFSF11), hepatokines (FGF21, IGFBP1), and diacylglycerol accumulation may represent downstream tissue-level consequences of sustained inflammatory activation. [Inferred]

**Causal inference opportunity:** In a longitudinal cohort, Granger causality or mediation analysis could test whether gut-derived metabolites (imidazole propionate, quinolinate) temporally precede cytokine elevation (IL6, IL18), and whether cytokine elevation in turn precedes vascular marker changes (SELE, MMP9). [Inferred]

### 7. Research Recommendations

#### Priority 1: High-Value Experimental Validations

1. **Measure serum GGT activity** and correlate with the module eigengene and the seven gamma-glutamyl dipeptide levels. [Inferred] If GGT activity explains the gamma-glutamyl signature, this establishes extracellular glutathione catabolism as a measurable component of the module's oxidative stress axis.

2. **Quantify imidazole propionate** in fasted plasma and test its correlation with HOMA-IR, IL6, and the module eigengene. [Inferred] If imidazole propionate is an upstream driver, its levels should precede (in longitudinal data) or independently predict (in cross-sectional data) the inflammatory protein response.

3. **Assess ADIPOQ module assignment:** Determine which WGCNA module contains adiponectin. [KG Evidence, Gap Analysis] If adiponectin resides in an anti-correlated module, this confirms the pro-inflammatory polarity interpretation and identifies a candidate protective module for comparative analysis.

#### Priority 2: Literature Validation of Emerging Connections

4. **DNER and Notch signaling in metabolic inflammation:** DNER's presence in this module is unexpected. [KG Evidence] A targeted literature review of DNER/Notch pathway roles in adipose tissue macrophage polarization or hepatic inflammation is warranted.

5. **SCGB3A2 as a compensatory anti-inflammatory signal:** SCGB3A2 is a lung-derived secretoglobin with anti-inflammatory properties. [KG Evidence] Its co-expression with inflammatory mediators raises the question of whether it represents a tissue-of-origin signal (lung involvement in the cohort) or a systemic anti-inflammatory counter-regulatory mechanism.

6. **FGF21 as a hepatic stress integrator:** FGF21 links mitochondrial dysfunction and ER stress to systemic metabolic adaptation. [Model Knowledge] Its co-expression with acylcarnitines (C3, C4, C5) and amino acids (glutamine, alanine) suggests hepatic mitochondrial stress is captured by this module. FGF21-to-acylcarnitine ratio could serve as a novel hepatic stress index.

#### Priority 3: Follow-Up Analyses

7. **Cross-module comparison:** Compare this Brown module's disease associations with those of the module containing BCAAs and the module containing adiponectin. [Inferred] The degree of overlap versus independence will clarify whether the inflammatory and metabolic axes of cardiometabolic risk are modular or hierarchical.

8. **Network medicine target identification:** The shared interaction partners identified by pathway enrichment (FADD, CASP8, RIPK1, KDR) represent potential pharmacological leverage points. [KG Evidence] TRAIL receptor agonists, anti-IL6 biologics (tocilizumab), and FGF21 analogues are in clinical development and could be evaluated for their effects on the entire module's expression profile.

9. **Dietary confounding analysis:** The presence of piperine metabolites, plant sterols (beta-sitosterol, campesterol), and carotenoids (beta-cryptoxanthin, carotene diols) suggests that dietary patterns co-vary with the module. [KG Evidence] Principal component analysis of the dietary metabolite subset, followed by adjustment of module-disease associations for this dietary component, would clarify whether the inflammatory signal is confounded by dietary exposure.

10. **Microbiome profiling:** The co-expression of imidazole propionate, stachydrine, betonicine, and piperine conjugates with inflammatory proteins motivates 16S rRNA or shotgun metagenomics sequencing in this cohort. [Inferred] Testing whether specific microbial taxa (particularly histidine-fermenting species producing imidazole propionate) correlate with the module eigengene would establish the microbiome as a modifiable upstream input to this inflammatory program.

---

*Report generated from KRAKEN knowledge graph analysis. All evidence tiers are tagged; findings marked [KG Evidence] derive directly from Kestrel query results. Claims marked [Literature] are supported by grounded abstracts listed in the Literature Evidence section. Claims marked [Model Knowledge] represent general biomedical knowledge not backed by KG queries or grounded literature in this analysis. Claims marked [Inferred] combine multiple evidence sources. Tier 3 predictions carry the standard calibration note: approximately 18% of computational predictions of this type progress to clinical investigation.*

### Literature References

Papers discovered via semantic search. 5 unique papers across 2 hypotheses.

| Hypothesis | Citation | Link | Relevance |
|------------|----------|------|-----------|
| Bridge: Gene → ChemicalEntity (2 hops) |  (2025) "A Theoretical Link Between the GH/IGF-1 Axis and Cytokine Family in Children: Current Knowledge and ..." | [Link](https://www.mdpi.com/2227-9067/12/4/495) | One of the consequences of inflammation is the induction of peripheral resistance to GH, which occurs through two major... |
| Bridge: Gene → SmallMolecule (2 hops) |  (2020) "Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway" | [Link](https://pubmed.ncbi.nlm.nih.gov/32130883/) | Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway Abstract Nicotinamide... |
| Bridge: Gene → SmallMolecule (2 hops) |  (2023) "Dysregulation of a lncRNA within the TNFRSF10A locus activates cell death pathways \| Cell Death Disc..." | [Link](https://www.nature.com/articles/s41420-023-01544-5) | The TNFRSF10A genomic locus contains three genes: the protein-coding tumor necrosis factor receptor superfamily member 1... |
| Bridge: Gene → SmallMolecule (2 hops) |  (2025) "Frontiers \| 1-methylnicotinamide modulates IL-10 secretion and voriconazole metabolism" | [Link](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1529660/full) | 1-M ... by the enzymatic ... of nicotinamide N-methyltransferase and is primarily distributed in the liver ( ... 3). Pre... |
| Bridge: Gene → ChemicalEntity (2 hops) |  (2020) "Frontiers \| Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Resp..." | [Link](https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2020.00605/full) | 2 genes: VCAN (rs44 ... 0745 and rs12 ... 2199) for ... A (rs20 ... 5 and rs17 ... 20) for missense. We technically ...... |